IP Library › Granted Patent US 11,920,189
Granted Patent B2
US 11,920,189 · App. 16/763,921 · Granted Mar 5, 2024

Methods and kits for amplification of double stranded DNA

Inventors: Ángel Joaquin Picher Serantes (Madrid, ES); Bettina Budeus (Mühlheim, DE)
Assignee: 4BASEBIO SL
C12Q1/6855C12Q2525/191C12Q2525/301C12Q2531/125
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,920,189
App. No.
16/763,921
Granted
Mar 5, 2024
Kind
B2
Abstract

Disclosed herein are devices and methods for amplifying double stranded DNA molecules. Methods for amplifying apoptotic cell-free DNA molecules can include performing end-repair and dA tailing of the cfDNA molecules, attachment of single-stranded hairpin adaptors to both ends of the end-repaired cfDNA molecules to produce adaptor-tagged, single-stranded, covalently closed DNA molecules, and amplification of the adaptor-tagged, single-stranded, covalently closed DNA molecules by a combination of rolling circle amplification and multiple displacement amplification using a PrimPol enzyme, a DNA polymerase with strand displacement activity and free nucleotides.

Claims (27)

1. A method of amplifying DNA comprising:

a) providing linear double-stranded DNA molecules;

b) attaching single-stranded adaptors comprising a non-complementary region of fewer than 25 nucleotides and comprising an XTC priming sequence, wherein X is A, C, G or T, to both ends of the linear double-stranded DNA molecules to produce single-stranded, covalently closed DNA molecules; and

c) amplifying the single-stranded, covalently closed DNA molecules in a single operation by (i) rolling circle amplification and (ii) multiple displacement amplification.

2. The method of claim 1 , wherein the linear double-stranded DNA molecules comprise apoptotic cell-free DNA molecules.

3. The method of claim 1 , wherein the linear double-stranded DNA is derived from one or more bodily fluids from mammals.

4. The method of claim 1 , wherein providing the linear double-stranded DNA comprises end-repair and/or dA-tailing.

5. The method of claim 1 , wherein the adaptors have a hairpin structure.

6. The method of claim 1 , comprising attaching adaptors having the following sequence: 5′TAACATTTGTTGGCCACTCAGGCCAACAAATGTTAT3′ [SEQ ID NO:1].

7. The method of claim 1 , comprising:

providing apoptotic cell-free DNA molecules;

performing end repair and dA tailing of the cell-free DNA molecules; and

ligating hairpin adaptors comprising a dT overhang to the end repaired, dA tailed cell-free DNA molecules.

8. The method of claim 1 , wherein amplification is primed by a primase/polymerase.

9. The method of claim 1 , wherein amplification is primed by Thermus thermophilus primase/polymerase (TthPrimPol).

10. The method of claim 1 , wherein amplification comprises strand extension using a polymerase having strand displacement activity.

11. The method of claim 1 , wherein amplification comprises primase-initiated multiple displacement amplification.

12. The method of claim 1 , comprising using a primase/polymerase to generate primers on the DNA and using a polymerase having strand displacement activity to extend the primers.

13. The method of claim 12 , wherein the primase/polymerase comprises TthPrimPol and the polymerase comprises Phi29 polymerase.

14. The method of claim 1 , further comprising:

d) sequencing the amplified DNA.

15. The method of claim 14 , further comprising:

e) detecting one or a plurality of genetic variants in the sequenced, amplified DNA.

16. The method of claim 2 , wherein the apoptotic cell-free DNA molecules have a length between about 140 bp and 180 bp.

17. The method of claim 3 , wherein the bodily fluids comprise one or more of CSF, blood, plasma, serum, ascites, urine, saliva, tear drops, milk, semen and synovial fluid.

18. The method of claim 1 , wherein the XTC priming sequence is located in the loop portion of the adapter.

19. The method of claim 1 , wherein amplification is primed by human primase/polymerase (HsPrimPol).

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 9, 2024
From: EXPEDEON LTD.
To: EXPEDEON SL.
Reel/Frame 067054/0222 →
Continuity (2)
Provisional Application 62589074 · Nov 21, 2017
Related Publication 20200362403A1 · Nov 19, 2020